Q4 2024 Earnings Call Transcript March 3, 2025 Fractyl Health, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $-0.44. Operator: Good afternoon, and ...
We completed our IPO debuting on the NASDAQ under the ticker symbol GUTS strengthening our financial position. Secured FDA IDE approval for a pivotal study of Revita’s role in weight maintenance ...
Abbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in ...
Abbott received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy (IVL) system.
FDA, has approved an investigational device exemption, IDE, for its Coronary Intravascular Lithotripsy, IVL, System to evaluate the treatment of severe calcification in coronary arteries prior to ...
today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) application to conduct a feasibility clinical trial to validate the safety of ...
During a live event, Patrick Moore, MD, discussed the superior efficacy with ide-cel vs standard care in relapsed/refractory ...
The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results